rare diseases clinical research network
Accelerates Rare Disease Data Center, Shrinks Pediatric Trial Window
Integrating Illumina sequencing with CD2B analytics cuts pediatric rare-cancer trial recruitment by 40 percent, shrinking the enrollment window dramatically. The acceleration comes from real-time variant calling and automated phenotype matching. Clinicians can move from sample to trial arm in days instead of weeks, per Illumina and CD2B internal analysis. Medical
